Phase I and pharmacokinetic (PK) Study of CP-724,714, an oral human epidermal growth factor receptor-2 (HER-2) selective tyrosine kinase inhibitor
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3082-3082
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3082-3082
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915
2003 ◽
Vol 94
(5)
◽
pp. 453-458
◽
2007 ◽
Vol 98
(12)
◽
pp. 1977-1984
◽
2015 ◽
Vol 16
(6)
◽
pp. e259-e261
◽
2008 ◽
Vol 99
(8)
◽
pp. 1611-1617
◽
2003 ◽
Vol 30
(3)
◽
pp. 261-262
◽